Superbug Pipeline Dwindles, New Drugs Offer Hope
Drug-resistant infections pose a grave threat, with deaths potentially doubling to eight million annually by 2050. A thin pipeline of new drugs, down from 92 to 60 in the last five years, is alarming. GlaxoSmithKline leads with 30 projects, but Pfizer has fallen behind. Despite this, three new antibiotics have been approved, and seven more are in late-stage trials, offering hope. The urgency for better treatments is high, especially in low- and middle-income countries where resistance is rising rapidly.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/b09b15baed37f791
Stryker Hit by Iranian-Backed Cyber Attack, Production Halted
Personal Trainer Pleads Guilty to Assault
Ireland's Renewable Energy Milestone: 8 Gigawatts
Lucan Special School Struggles with Full Days
Finglas School Faces Delays in Special Classes
Couple's Fight for Justice Leads to Pregnancy Misdiagnosis Review
IRA Leadership Questioned in London Court Case
Trump Raises Safety Concerns for Iran's World Cup Team
Man with Knife in Cork: Judge Orders Psychiatric Help
Starmer Pledges UK-NI Cooperation for Heating Oil Relief
TouchStore Irish PGA Championship Returns to Limerick
Dancing with the Stars Finale: Paudie's Journey
Water Disruptions Alert: O'Connell Street Repairs